A series of WHO PQ triggers vaccines development of domestic pharmaceutical companies
A series of the WHO PQs by domestic pharmaceutical and biopharmaceutical companies are expected to accelerate the domestic vaccine development.
A pentavalent complex vaccine developed by LG Life Sciences for the first time using domestic technology, ‘Eupenta’ has acquired prequalification from t...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
